KATHMANDU, May 12: A total of 32,000 vials of Remdesivir have been brought to Nepal from Bangladesh for the treatment of coronavirus infection.
Of the total Remdesivir, 10,000 vials were brought by the government and the 22,000 vials were brought by Ayaan Healthcare Pvt Ltd, Kupondole on Tuesday. According to Dr Mohammad Kalam, Director of Ayaan Healthcare, the medicine was brought in a chartered plane.
Dr Jageshwar Gautam, Spokesperson at the Ministry of Health and Population, informed that the Remdesivir medicine arrived from Bangladesh on Tuesday evening. According to him, the medicine brought by the government will be distributed in government hospitals. The medicine will be distributed free of cost in government hospitals. “The price of the medicine brought by the suppliers has been fixed at around Rs 5,000,” said Spokesperson Gautam.
Kalam said that the medicine was supplied from Bangladeshi pharmaceutical company Incepta.
Remdesivir is an investigational broad-spectrum antiviral agent, which has been proven efficient in vitro activity against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). It is now considered as a potential therapeutic agent against COVID-19 that is helpful mainly to patients, who need ventilator support, to fight against the pandemic.